Description.
June 2018 • 06/07/2018, New York For Immediate Release Green Circle Capital, a leading boutique investment bank that primarily serves the natural products industry and related verticals, is pleased to announce the closing, on April 20, 2018, of the sale of Genesis Today (makers of plant-based nutritional and nutraceutical products). Green Circle was engaged … Read more
September 2020 • 9/28/2020, New York In June of 2017 Green Circle was the exclusive sellside adviser for Marley Beverage Company in their sale to New Age Beverages. The deal was a virtual case study in maximizing value from an uncertain asset, and an illustration of the value of operational experience in the beverage … Read more
July 2016 • 9/28/2016, New York IN JUNE OF 2016 GREEN GREEN CIRCLE RAISES SERIES A-1 PREFERRED EQUITY CAPITAL RAISE FOR KARMA CULTURE LLC. New York, NY July 12, 2016 – Green Circle Capital Partners is pleased to announce the completion of an equity capital raise for Karma Culture LLC, makers of Karma Wellness … Read more
September 2018 • New York As seen in Beverage Business Insights on January 10, 2019: BEVERAGE BUSINESS INSIGHTS, published 100+x a year, Vol 16 No 5 | Jan 10, 2019, Publisher: Benj Steinman, Editor: Gerry Khermouch, Senior Editor: Jim Sullivan STRATEGY: Good Response to Sparkling Extension Prompts Next Evolution of Gloe Water, with Botanical Ingredients Now Heading to Core … Read more
September 2020 • 9/28/2020, New York IN JUNE OF 2012 GREEN CIRCLE LED THE $3.7 MILLION SERIES B PREFERRED EQUITY FINANCING FOR REMEDY PHARMACEUTICALS, INC., AND RAISED ADDITIONAL CAPITAL IN NOVEMBER OF 2013. INVESTORS ENJOYED AN EXIT IN MAY 2017. Remedy Pharmaceuticals, Inc. is a clinical stage pharmaceutical company focused on the development and … Read more
2013 • New York IN MARCH OF 2013 FIZZY LIZZY WAS ACQUIRED BY THE WHITEROCK BEVERAGE COMPANY Green Circle Capital Partners LLC is proud to announce that a principal of the firm has advised Fizzy Lizzy on the successful sale of the brand to White Rock Beverage Company in a private transaction, the terms … Read more
September 2020 • 9/28/2020, New York DECEMBER OF 2012, PARTICIPATED IN THE SERIES A PREFERRED EQUITY FINANCING FOR CRITICAL CARE DIAGNOSTICS, INC. Critical Diagnostics helps physicians optimize patient care in cardiovascular diseases, such as heart failure. Their high sensitivity Presage® ST2 Assay measures the level of soluble ST2 in blood, identifying patients at increased … Read more
